Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevin G. Lokay currently holds 10,000 shares of CYTOGEN CORP (CYTO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevin G. Lokay has been a net neutral trader of CYTO stock. They have purchased $0 and sold $0 worth of shares.
Kevin G. Lokay's most recent insider trade was on Aug 3, 2026, when they sold 240 shares at $0.00 per share.
Kevin G. Lokay serves as Executive at CYTOGEN CORP (CYTO). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Kevin G. Lokay holds the position of Executive at CYTOGEN CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Kevin G. Lokay has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Kevin G. Lokay was on Aug 3, 2026, when they sold $0 worth of GRTX shares. This transaction involved 240 shares at N/A per share.
Kevin G. Lokay currently owns 10,000 shares of CYTOGEN CORP (CYTO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevin G. Lokay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevin G. Lokay has 4 Form 4 filings on record as an insider at CYTOGEN CORP.
Set alerts for Kevin G. Lokay and 40,000+ other insiders.